China's CRO Industry Pulling Out All Stops In The Year Of The Tiger (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - By the end of 2009 there were roughly 500 contract research organizations in China, most of which are small registration consultants, and about 150 execute research work. Driven by the trend to offshore R&D work from big pharmas and the double digital growth of the Chinese market, the number of CRO companies is expected to increase further and offer broader services in the upcoming Chinese Year of The Tiger